VBI Vaccines, Inc. - Ordinary Shares (VBIV) Social Stream



VBI Vaccines, Inc. - Ordinary Shares (VBIV): $0.59

-0.03 (-4.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VBIV to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

VBI VACCINES INC (VBIV) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering VBIV.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-01 3 $9 $8 $8.5 $0.6 1316.67%
2022-03-07 3 $9 $6 $7.666 $0.6 1177.67%
2022-05-11 2 $8 $6 $6.666 $0.6 1011%
2022-08-08 3 $8 $6 $6.666 $0.6 1011%
2022-08-09 3 $7 $5 $6 $0.6 900%
2022-11-11 2 $6 $2 $4 $0.6 566.67%

The Trend in the Analyst Price Target


VBIV's average price target has moved down $1.67 over the prior 27 weeks.

VBIV reports an average of 552.16% for its upside potential over the past 36 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-07 3 9 6 7.666 1.330 476.39%
2022-03-14 3 8 6 6.666 1.270 424.88%
2022-08-08 3 8 6 6.666 1.040 540.96%
2022-11-11 2 7 2 5.000 0.597 737.52%
2022-11-11 3 7 2 5.000 0.597 737.52%

VBIV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 1 1 0 0 0 2

The Trend in the Broker Recommendations


Over the past 35 weeks, VBIV's average broker recommendation rating worsened by 0.33.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, VBI VACCINES INC's upside potential (average analyst target price relative to current price) is higher than 776.6% of them.
  • VBI VACCINES INC's average analyst price target is higher than 46.36% of all US stocks.
  • In terms of how VBI VACCINES INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 59.92% of that group.
  • In the context of Pharmaceutical Products stocks, VBI VACCINES INC's variance in analysts' estimates is lower than -143.85% of them.

Stocks similar to VBI VACCINES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ATNF, ATNX, and GTHX.

Make investment decisions regarding VBIV using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8179 seconds.